TmMSTN-01
/ University of Pennsylvania, Gilead
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 02, 2024
CAR T Cells in Mesothelin Expressing Cancers
(clinicaltrials.gov)
- P1 | N=54 | Completed | Sponsor: University of Pennsylvania | Active, not recruiting ➔ Completed | Trial completion date: Mar 2025 ➔ Jul 2024 | Trial primary completion date: Mar 2025 ➔ Nov 2023
CAR T-Cell Therapy • Trial completion • Trial completion date • Trial primary completion date • Fallopian Tube Cancer • Lung Adenocarcinoma • Lung Cancer • Malignant Pleural Mesothelioma • Mesothelioma • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Peritoneal Cancer • Solid Tumor • PD-L1
November 02, 2023
CAR T Cells in Mesothelin Expressing Cancers
(clinicaltrials.gov)
- P1 | N=65 | Active, not recruiting | Sponsor: University of Pennsylvania | Recruiting ➔ Active, not recruiting | N=27 ➔ 65
CAR T-Cell Therapy • Enrollment change • Enrollment closed • Fallopian Tube Cancer • Lung Adenocarcinoma • Lung Cancer • Malignant Pleural Mesothelioma • Mesothelioma • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Peritoneal Cancer • Solid Tumor • PD-L1
1 to 2
Of
2
Go to page
1